Acme United Corporation Recalls Dukal BZK Antiseptic Towelettes Due to CGMP Deviations
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Acme United Corporation has voluntarily recalled several lots of Dukal BZK Antiseptic Towelettes distributed nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 2, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, antiseptic.
What Happened
Acme United Corporation has initiated a voluntary recall of Dukal BZK Antiseptic Towelettes. The recall, classified as Class II by the FDA, was prompted by Current Good Manufacturing Practice (CGMP) deviations. The recall was officially initiated on January 20, 2026, following notification sent to distributors and customers via letter.
Which Products Are Affected
The recall affects Dukal BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) packaged in cases of 1,000 packs. The product is identified by NDC 65517-0004-1 and was manufactured for Dukal, LLC.
The following lot numbers and expiration dates are included in this recall:
- Lot MN31621: Expiration October 2026
- Lots MN14522, MN15522: Expiration April 2027
- Lots MN28122, MN31522: Expiration September 2027
- Lots MN04223, MN06023: Expiration February 2028
- Lot MN17223: Expiration May 2028
- Lot MN25123: Expiration August 2028
- Lots MN33123, MN33523: Expiration November 2028
These products were distributed nationwide within the United States.
What You Should Do
Consumers, retailers, and healthcare providers should immediately check their inventory for the affected lot numbers listed above. If you possess any of the recalled towelettes, you should stop using them. Acme United Corporation initiated the notification process via letter; affected parties should follow the instructions provided in that communication for the return or disposal of the product. For further information, the recalling firm is located in Shelton, CT.
Why This Matters
This recall is significant because CGMP deviations indicate that the manufacturing process did not meet the required regulatory standards to ensure the product's quality, strength, and purity. A Class II classification suggests that use of the product may cause temporary or medically reversible adverse health consequences.
Source
Information provided by the FDA under recall number D-0360-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.